Dr Peddi on Navigating Disease Progression in HR+/HER2− Breast CancerByPrakash Peddi, MDNovember 13th 2026Disease progression rate and emerging ESR1 alterations help guide subsequent treatment decisions in HR+/HER2− breast cancer.